Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

shutterstock 521449360

News and Trends 15 Dec 2016

Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials

Kiadis Pharma has received approval to test in the UK an immune therapy to address the big challenges of bone marrow transplants, currently the only cure for blood cancers. Kiadis Pharma, based in Amsterdam, is working on therapies to improve the outcome of hematopoietic stem cell transplantation (HSCT), a common treatment for multiple types of […]

December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 14 at 5.15.56 PM e1481732282873

News and Trends 15 Dec 2016

This Biofuel Company partnered with Audi is about to shake the Oil Market

At Labiotech Refresh we had the opportunity to chat with Marc Delcourt, founder and CEO of Global Bioenergies, a biofuel pioneer challenging the oil market. Global Bioenergies, from France, uses synthetic biology to produce isobutene, the “building block of the chemical industry“. This molecule, currently extracted from oil, is essential for the manufacturing of gasoline, rubber, […]

December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 07 at 3.46.36 PM e1481122126679

News and Trends 15 Dec 2016

UPDATE: European Stem Cell Therapy Pioneer goes for €34M IPO

TiGenix is entering the Nasdaq with an IPO aimed at funding clinical trials. Will this move allow the company to make it through clinical trials? TiGenix is a Belgian company behind ChondroCellect, the first cell therapy approved on the European market. The biotech has now announced a Nasdaq IPO that aims to raise €39.8M in order to fund […]

December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 535356580 1

News and Trends 15 Dec 2016

10 Awesome Biotech Gifts for you and your Geekiest Loved Ones

Stuck on what to get your family and friends for Christmas? What about portable lab equipment or a stuffed version of your favorite microorganism? Biotech is one of the fastest growing sectors worldwide and a big employer in Europe. Providing solutions to cure, feed and fuel the world, who wouldn’t want to brag about this amazing field? Whether […]

December 15, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

kentoh

News and Trends 14 Dec 2016

Deloitte’s Message to Pharma: Learn from Biotech or Perish

The consulting firm’s annual financial report suggests pharma’s current model is not sustainable. The solution? Be more like biotech. Pharma has had a rollercoaster of a year, from anxiety about the US election to stellar CAR-T results after patient deaths. Overall, however, the numbers have not been great, and a new report from the analysts at […]

December 14, 2016 - 2 minutesmins - By Evelyn Warner

Sirirat

News and Trends 14 Dec 2016

Liquid Biopsies: Lowering the Defenses of Resistant Lung Cancer

In response to new treatments, cancer came back stronger and more resistant than ever. Medicine’s counterattack will be more effective with a clear target. How do you solve a problem like drug resistance in cancer research? There’s no clear-cut answer yet, not least because the disease can vary so widely. But there has been some […]

December 14, 2016 - 4 minutesmins - By External Contributor

ADVERTISEMENT

virus1 gray e1481711164878

News and Trends 14 Dec 2016

Swedish Therapy targeting All Solid Tumors enrolls First Patient

Immunicum just received FDA approval to start clinical trials in the US for a therapy that could overcome the challenges of T-cell therapies and target virtually any injectable solid tumor. Immunicum is a biotech from Gothenburg, Sweden, that focuses on immuno-oncology with a different approach from most companies. Instead of T-cells, the company engineers dendritic […]

December 14, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Dec 2016

UPDATE: Bayer seals deal with Monsanto in Dark Side slide

Bloomberg reports that Bayer has increased its bid once more to acquire the world’s least ethical company in order to solidify its position in agrochemicals. Bayer appears hell-bent on a Faustian bargain with Monsanto: the German chemical company has just thrown more money at America’s fourth most hated company in the hope of acquiring it. Despite its […]

December 14, 2016 - 3 minutesmins - By Evelyn Warner

urfin

News and Trends 14 Dec 2016

What do the CAR-T Patient Deaths Mean for the Future of the Field?

Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite the bad news, hopes for CAR-T therapies remain high. Juno Therapeutics again came under scrutiny last month following deaths in its JCAR015 trial. Two patients died from neurotoxicity-triggered cerebral edema, the same condition that killed […]

December 14, 2016 - 7 minutesmins - By Diana Kwon

Chelsea Cameron

Interview 13 Dec 2016

Meet the French Seaweed Startup rethinking Bioplastics

Algopack is a French startup manufacturing bio-based materials made from brown algae. It is the first to use it to develop a new generation of bioplastics. Founded by Rémy Lucas in 2010 and managed by David Coti, Algopack offers a breakthrough innovation using marine natural resources as a unique renewable biomass. The company hopes to […]

December 13, 2016 - 3 minutesmins - By Nicolas Sainte-Foie

microbial resistance header

News and Trends 13 Dec 2016

How Will Biotech Overcome the Huge Challenges of Microbial Resistance?

The emergence of multi-drug resistant pathogens is alarming the scientific community since their growth is increasing at an incredibly fast pace. We gathered a group of experts to discuss how biotech is addressing this pressing concern and what the next big thing will be in the field of antimicrobial resistance. Achim Plum, CCO of Curetis, highlighted that […]

December 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Yuval Helfman

News and Trends 13 Dec 2016

European Pharma closes 2016 by launching new Biotech Startups

Big pharma is already head on starting 2017 with a bang. Pfizer and Bayer are launching US-based startups in oncolytic virus and stem cell therapies. Pharma is wrapping up 2016 by investing in a pair of new ventures. Bayer and Versant have invested $225M to launch BlueRock Therapeutics, which will focus on CNS and cardiovascular diseases. This comes […]

December 13, 2016 - 2 minutesmins - By Evelyn Warner

ADVERTISEMENT